Peptides for Dogs: Complete Guide to Canine Peptide Therapy

The logic is blunt: dogs get the same tissue problems humans do — but on a compressed timeline, and without the option of "rest for six weeks." Tendon and ligament injuries in working and sporting dogs, osteoarthritis in seniors, post-surgical recovery, and age-related decline are all conditions where peptide research (almost entirely rodent, with some equine and emerging canine data) shows tissue-repair signaling effects. The same angiogenesis, collagen-synthesis, and cell-migration mechanisms that make BPC-157 popular in human recovery research are exactly what a lame dog's damaged tendon needs.

Honest evidence framing: virtually every peptide used in dogs is extrapolated from rodent and lab studies. Veterinary clinical data is thin but growing. That means dosing is conservative, monitoring matters more, and your veterinarian must be part of any protocol — not a postscript to it.

• •Doses are per kilogram and smaller: dogs are dosed at roughly 5–10 mcg/kg for BPC-157 — NOT the fixed 250–500 mcg adult-human dose. A beagle and a Great Dane share a formula, not a dose.
• •Breed size adjusts everything: small breeds run lower absolute doses (and are more sensitive per kg); large and giant breeds can need 10–15% more per kg for TB-500. The dose tables below handle this.
• •Cycle lengths are shorter in calendar time: 4–6 weeks on, 4 weeks off is the standard canine cycle.
• •Never use a human protocol on a dog: human doses scaled down can still overshoot, and human cycle assumptions (16–24 weeks for GLP-1s) make no sense for a species that metabolizes faster.
• •Oral routes matter more for dogs: pilling an oral capsule into a bit of food is easier and less stressful than daily SC injections for many owners.

This is exactly why PeptideWise built a separate dog protocol builder — the engine runs dog-specific per-kg dosing, breed-size adjustments, and canine contraindications, none of which the human engine assumes.

BPC-157 is the most widely used healing peptide in veterinary practice. In dogs it is studied and used mostly for tendon, ligament, and joint repair — the cruciate-ligament tears, chronic Achilles issues, and post-op orthopedic recoveries that sideline athletic and senior dogs alike. The oral form is used for GI lining support. Full details on the BPC-157 for dogs page.

Subcutaneous injections in dogs are given in the scruff or loose skin along the flank — a low-stress location most dogs tolerate well. For GI protocols, oral BPC-157 capsules (or powder in food) reach the stomach intact: its acid stability is the whole point of the compound.

TB-500 (thymosin beta-4 fragment) is BPC-157's partner in canine injury work — promoting cell migration, tissue remodeling, and reduced inflammation. It is dosed on a different rhythm: larger, less frequent doses twice weekly, which is why the two peptides interleave so well in canine protocols. Details on the TB-500 for dogs page.

Joints and injury recovery are the flagship uses, but the canine toolkit covers most of what aging dogs face:

Each has its own dog peptide page with dosing, cycle structure, and evidence level — all follow the same conservative per-kg framework.

The senior-dog logic: from ~7–8 years (large breeds) or ~10 years (small breeds), dogs accumulate exactly the cellular wear peptides were studied for. Anti-aging protocols in the veterinary research community lean on three compounds:

• •Epithalon — the telomere-associated peptide; used in senior protocols for broad cellular-maintenance support.
• •NAD+ precursors/infusions — supporting mitochondrial function, which is the root of canine (and every other) aging process.
• •GHK-Cu — copper-binding tripeptide used for skin, coat, and general tissue maintenance in seniors.

Senior protocols are gentle cycles — 4–6 weeks on, longer breaks, one compound at a time at the low end of the dose range — because a 12-year-old dog's capacity to handle anything new is fundamentally different from a 3-year-old working dog's.

• •Puppies under 1 year: no peptide protocols. Growing tissue and developing immune systems are not research targets.
• •Pregnant or nursing dogs: excluded from every protocol, full stop.
• •Cancer or active tumors: BPC-157 is pro-angiogenic — tumors exploit new blood-vessel growth. Absolute exclusion.
• •Autoimmune conditions: TB-500 and immune-active peptides are excluded.
• •Upcoming surgery: hold all peptides 1–2 weeks before a planned operation.
• •NSAIDs and anticoagulants: BPC-157 may modulate coagulation pathways — timing with Rimadyl, carprofen, or blood thinners is a veterinary decision, not an owner one.
• •One compound at a time: any reaction must be attributable, especially in an animal who cannot report one.
• •Veterinary involvement: your vet should know what your dog is on. This is not optional in the way it unfortunately is in human peptide use — vets can actually run the labs.

The clearest breed-specific line in canine peptide use is the MDR1 (ABCB1) gene mutation carried by herding breeds: Collies, Shetland Sheepdogs, Australian Shepherds, German Shepherd-type lines, and related herding dogs. MDR1-positive dogs are unusually sensitive to a wide range of drugs because the mutation impairs the blood-brain barrier's ability to pump drugs back out of the central nervous system. Confirm MDR1 status with your veterinarian before starting any new compound in a herding breed — a $60 DNA test beats a bad reaction.

Beyond MDR1, the practical breed rules are structural: brachycephalic breeds (bulldogs, pugs) need the gentlest titration and most conservative dosing because they metabolize and clear drugs less predictably; giant breeds (Great Danes, Wolfhounds) get the high end of weight dosing for TB-500 but need joint-specific monitoring; and sighthounds (greyhounds, whippets) are famous for atypical drug metabolism across the board — start at the low end of everything.

The practical starting sequence: identify the specific goal (joint repair? senior support? post-surgical recovery?), get a veterinary diagnosis of what is actually wrong, then build the protocol around the dog's weight and your monitoring capacity. The dog protocol builder walks through this — weight-based doses, cycle calendars, contraindication screening, and breed-size adjustments — and the PeptideWise Pets hub covers every canine peptide in detail.